Form 4 for HQL abrdn Life Sciences Investors
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-30 · accession 0001510281-25-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-02-03 | 2025-01-30+ | HQL | Weinstein Boaz | 10% | S - Sale | $14.21 | -37.0K | 3.40M | -1% | -$525.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | S | D | 15,143 | $14.27 | 3,381,371 | I - | — | — | |
| 2 | Common | Common Stock | 2025-01-30 | S | D | 21,835 | $14.16 | 3,396,514 | I - | — | — |